The Mesothelioma Victims Center's motto is nothing but the best. The group says, "in just three years we have created a absolutely free service for just diagnosed victims of mesothelioma cancer, that is unparalleled in the United States." The Mesothelioma Victims Center says, "we provide just diagnosed victims of mesothelioma help with Social Security, or VA Disability, we provide the individuals with a personalized report detailing specific health care options in their area, and we give the mesothelioma victim the names, and contact info of the most successful mesothelioma trial law firms, or lawyers in the United States." They say, "we know there are so many lawyers trying to exploit a mesothelioma victim, as something to sell, to an actual mesothelioma law firm, with slick TV, Internet or radio ads, but mesothelioma victims are finding us, they are calling us, and then they are then calling us back to say thank you." If you, or a family member has just been diagnosed with a rare form of cancer please call the Mesothelioma Victims Center for the most comprehensive free service in the United States at 866-714-6466 , or contact the group via its web site at http://MesotheliomaVictimsCenter.Com
Showing posts with label Mesothelioma. Show all posts
Showing posts with label Mesothelioma. Show all posts
Thursday, 28 July 2011
Mesothelioma may be caused by exposure to ultramafic rock
Everyday exposure to naturally occurring asbestos increases the risk of developing malignant mesothelioma, according to a study by UC Davis researchers.
The study - the largest to examine the question - will be published this fall in the American Journal of Respiratory and Critical Care Medicine.
Exposure to asbestos in the workplace, particularly in shipyards, has long been recognized as a risk factor for mesothelioma, a rare form of cancer affecting the lining of the lung. But in the new study, researchers found a consistent and dose-dependent association between mesothelioma and residential proximity to ultramafic rock, the predominant source of naturally occurring asbestos.
"Our findings indicate that the risks from exposure to naturally occurring asbestos, while low, are real and should be taken seriously," said Marc Schenker, professor and chair of the UC Davis Department of Public Health Sciences and the study's senior author. "This study provides important supportive evidence that naturally occurring asbestos causes mesothelioma - and public efforts should now shift to understanding the risk and how we can protect people from this preventable malignancy."
To put the mesothelioma risk in perspective, the disease kills about the same number of Americans each year as passive smoking. About 2,500 people a year die from mesothelioma in the United States, according to National Institute of Occupational Safety and Health statistics. About 3,000 deaths a year are attributed to exposure to secondhand tobacco smoke, according to U.S. Environmental Protection Agency statistics.
Ultramafic rock is distributed throughout the Sierra Nevada, Coast Ranges and Klamath Mountains in Northern and Central California, and has been a source of increasing concern as new housing developments cut through these areas. Of most concern are the areas of ultramafic rock associated with tremolite asbestos.
In their ambitious study, Schenker and his colleagues used California Cancer Registry data to identify 2,908 cases of malignant mesothelioma diagnosed between 1988 and 1997 in adults ages 35 and older. In most cases, the registry also provided occupational history. As a control group, an equal number of age- and gender-matched pancreatic cancer cases was selected (since pancreatic cancer has no known association to asbestos exposure). For both the mesothelioma and pancreatic cancer cases, the researchers employed sophisticated geographic information system mapping to pinpoint home or street addresses for every diagnosed individual. A map from the California Department of Conservation, Division of Mines and Geology, served as the reference for ultramafic rock deposits. Finally, statistical adjustments were made for sex, occupational asbestos exposure and age at diagnosis.
The researchers found that the risk of developing malignant mesothelioma was directly related to residential proximity to a source of ultramafic rock. Specifically, the odds of having mesothelioma fell by 6.3 percent for every 10 kilometers (about 6.2 miles) farther a person lived from the nearest asbestos source. The association was strongest in men, but was also seen in women. No such association showed up in the pancreatic cancer group. The study was not designed to determine the "ground zero" risk for those living closest to an asbestos source - only to test for a relationship between proximity and risk.
"This is very creative, painstaking epidemiology," said Jerrold L. Abraham, professor and director of environmental and occupational pathology at SUNY Upstate Medical University in Syracuse, New York, and a leading authority on mesothelioma. "The UC Davis researchers have shown a significant association between living near deposits of naturally occurring asbestos and mesothelioma. This is the strongest evidence possible without conducting one-on-one interviews with each diagnosed mesothelioma patient or his or her family."
Laurel Beckett, professor and vice chair of the UC Davis Department of Public Health Sciences and a study co-author, said the findings are important. "We showed that breathing asbestos in your community is not magically different from breathing asbestos in an industrial setting. It would have been a surprise to find otherwise."
The study - the largest to examine the question - will be published this fall in the American Journal of Respiratory and Critical Care Medicine.
Exposure to asbestos in the workplace, particularly in shipyards, has long been recognized as a risk factor for mesothelioma, a rare form of cancer affecting the lining of the lung. But in the new study, researchers found a consistent and dose-dependent association between mesothelioma and residential proximity to ultramafic rock, the predominant source of naturally occurring asbestos.
"Our findings indicate that the risks from exposure to naturally occurring asbestos, while low, are real and should be taken seriously," said Marc Schenker, professor and chair of the UC Davis Department of Public Health Sciences and the study's senior author. "This study provides important supportive evidence that naturally occurring asbestos causes mesothelioma - and public efforts should now shift to understanding the risk and how we can protect people from this preventable malignancy."
To put the mesothelioma risk in perspective, the disease kills about the same number of Americans each year as passive smoking. About 2,500 people a year die from mesothelioma in the United States, according to National Institute of Occupational Safety and Health statistics. About 3,000 deaths a year are attributed to exposure to secondhand tobacco smoke, according to U.S. Environmental Protection Agency statistics.
Ultramafic rock is distributed throughout the Sierra Nevada, Coast Ranges and Klamath Mountains in Northern and Central California, and has been a source of increasing concern as new housing developments cut through these areas. Of most concern are the areas of ultramafic rock associated with tremolite asbestos.
In their ambitious study, Schenker and his colleagues used California Cancer Registry data to identify 2,908 cases of malignant mesothelioma diagnosed between 1988 and 1997 in adults ages 35 and older. In most cases, the registry also provided occupational history. As a control group, an equal number of age- and gender-matched pancreatic cancer cases was selected (since pancreatic cancer has no known association to asbestos exposure). For both the mesothelioma and pancreatic cancer cases, the researchers employed sophisticated geographic information system mapping to pinpoint home or street addresses for every diagnosed individual. A map from the California Department of Conservation, Division of Mines and Geology, served as the reference for ultramafic rock deposits. Finally, statistical adjustments were made for sex, occupational asbestos exposure and age at diagnosis.
The researchers found that the risk of developing malignant mesothelioma was directly related to residential proximity to a source of ultramafic rock. Specifically, the odds of having mesothelioma fell by 6.3 percent for every 10 kilometers (about 6.2 miles) farther a person lived from the nearest asbestos source. The association was strongest in men, but was also seen in women. No such association showed up in the pancreatic cancer group. The study was not designed to determine the "ground zero" risk for those living closest to an asbestos source - only to test for a relationship between proximity and risk.
"This is very creative, painstaking epidemiology," said Jerrold L. Abraham, professor and director of environmental and occupational pathology at SUNY Upstate Medical University in Syracuse, New York, and a leading authority on mesothelioma. "The UC Davis researchers have shown a significant association between living near deposits of naturally occurring asbestos and mesothelioma. This is the strongest evidence possible without conducting one-on-one interviews with each diagnosed mesothelioma patient or his or her family."
Laurel Beckett, professor and vice chair of the UC Davis Department of Public Health Sciences and a study co-author, said the findings are important. "We showed that breathing asbestos in your community is not magically different from breathing asbestos in an industrial setting. It would have been a surprise to find otherwise."
Monday, 25 July 2011
Mesothelioma Expected To Rise Greatly
With today’s time and age, everything is faster. Technology, manufacturing, and even expectations have become faster, and more diligent than ever. However, something that is increasing a rapidly dangerous rate is case that involves asbestos, which leads to mesothelioma.
Asbestos, once used for many products that we use on a daily basis, such as housing materials, has recently been banned and refused by many. The substance has been known to cause the deadly disease mesothelioma, which affects the pleural lining and cavity within an individual, to occur. This disease can easily lead to the severe illness, and eventual death of the victim. However, the diagnoses of such as disease can only actual are available up to forty years after the person has actually been exposed to the substance. This is due to the disease lying dormant within a person.
In Oak Ridge, Tennessee, recently, a postal service building was reported to have the substance asbestos within floor tiles, as well as particles within the air. The federal reports state that everyday over forty employees pass through the building picking up their mail loads, as well as individuals that are not even associated with the post office, coming to simply drop off a package and mail something. Also, the particular postal office is where all of the Oak Ridge mail comes from, which means that if even a tiny bit of airborne substances occurring from the asbestos could easily get onto the envelopes of citizens.
In May 2011, a public citation from the Occupational Safety and Health Administration was issued. It stated that the postal service employees of the Oak Ridge location as well as some citizens could be exposed to the asbestos, which inevitably could be the later cause of severe illness, or death. The claim that the post office had no knowledge of such occurrences taking place has been supported by the OSHA, and their penalty was reduced from $1,500 to $750.
Although the post office had no knowledge of the instance-taking place, shouldn’t they know? It is their right to, as a public entity, be a place of a safe manner that people can rely on to do their daily tasks without risking their health, well-being, and future lives in any way, shape, or form. Hopefully with this instance occurring, many more government run programs will be inspected properly to insure safety to all.
Mesothelioma Victims Center Urges US Navy Veterans & Individuals With Mesothelioma To Call Them For The Names Of The Best Mesothelioma Lawyers & Treatment Options
When it comes to advocacy for US victims of mesothelioma, the Mesothelioma Victims Center has no equal. Not only will the group produce a customized treatment options report detailing the best mesothelioma cancer treatment options in the specific area, state, and region, for a victim, or a family dealing with mesothelioma, but as importantly the group will tell a US Navy Veteran, an individual, or their family, what mesothelioma lawyers are the most successful in the nation. The group says, "We have gone through the heartache of mesothelioma first hand. We know that most families have never heard of mesothelioma, we also know that most families have to start from scratch, in trying to figure out who best to call, or what are the best things to do after receiving the news of a mesothelioma diagnosis. No group in the nation is better branded on helping a US Navy Veteran, an individual, or a family dealing with mesothelioma, and no group in the nation offers anything close to our comprehensive free service." For more information on the Mesothelioma Victims Center's unparalleled free service, individuals, or families dealing with a mesothelioma diagnosis are urged to call the group anytime at 866-714-6466, or they can contact the group via their web site at http://MesotheliomaVictimsCenter.Com
Rsre work technique linked to artist's mesothelioma cancer death
A SCOTS artist who died earlier this month had a rare cancer normally caused by asbestos.
It's thought the clouds of dust James Howie worked in may have led to his death.
The Dundonian used an unusual technique of sanding down layers of paint to create his distinctive landscapes.
His cause of death was given as pulmonary embolism - a blocked artery to the lungs - and mesothelioma, which is a cancer usually found among shipyard workers exposed to asbestos.
Last night, his 74-year-old widow Joyce said: "He had mesothelioma, which he could have contracted at any time during his work.
"He used to do layer upon layer of paint, always scraping, sanding, cutting it back to paint over it again and again in order to create a certain effect.
"He would keep repeating this process until it resulted in the thing he was looking for. Although we have the death certificate, we're still awaiting the results of a final autopsy."
It's thought the clouds of dust James Howie worked in may have led to his death.
The Dundonian used an unusual technique of sanding down layers of paint to create his distinctive landscapes.
His cause of death was given as pulmonary embolism - a blocked artery to the lungs - and mesothelioma, which is a cancer usually found among shipyard workers exposed to asbestos.
Last night, his 74-year-old widow Joyce said: "He had mesothelioma, which he could have contracted at any time during his work.
"He used to do layer upon layer of paint, always scraping, sanding, cutting it back to paint over it again and again in order to create a certain effect.
"He would keep repeating this process until it resulted in the thing he was looking for. Although we have the death certificate, we're still awaiting the results of a final autopsy."
Hawaii Researchers’ Efforts to Crack Mesothelioma Code Aided by $3.5m Gift
Michele Carbone, director of the University of Hawaii Cancer Center and his colleagues, have made a series of recent scientific breakthroughs in understanding the mechanism by which asbestos triggers mesothelioma, an aggressive cancer of the lining of the lung and abdomen.
In recognition of that groundbreaking research, an anonymous donor has given the University of Hawaii Cancer Center a $3.58 million gift to support mesothelioma research, the university announced this month. The gift is the second largest in UH Cancer Center history.
“Mesothelioma is a serious public health problem,” said Virginia Hinshaw, chancellor of the University of Hawaii Manoa. “We’re proud that Dr. Carbone’s team is leading the world in this area of discovery. This gift validates their efforts and will help them remain at the forefront of thoracic oncology research.”
Closely associated with inhaling airborne asbestos fibers, mesothelioma produces an aggressive type of tumor. The current median survival from diagnosis is just 12 months, creating a need for more effective therapies to extend mesothelioma patients’ lives. Approximately 2,500 to 3,000 people in the U.S. are diagnosed with mesothelioma each year. Most were exposed to asbestos decades before cancer symptoms appeared.
Dr. Carbone and colleagues including Assistant Professor Haining Yang and Adjunct Professor Giovanni Gaudino have studied asbestos-related disease for more than a decade, analyzing how genetics, environmental carcinogens and viral infection interact to cause malignant mesothelioma.
In an article in the Proceedings of the National Academy of Sciences, Carbone and colleagues described how asbestos killed cells through a process called programmed cell necrosis that leads to the release of a protein molecule HMGB1. People exposed to asbestos have elevated levels of the protein in their blood. The protein begins an inflammatory chain reaction in tissue that causes the release of mutagens that promote tumor growth. Cancer often occurs in the presence of chronic inflammation. By interfering with the inflammatory reaction, it may be possible to decrease the occurrence of mesothelioma.
Many of the UH researchers’ findings have been based on work conducted in the villages of Capadoccia, a region of Turkey that has an extraordinarily high rate of mesothelioma deaths. Nearly 50 percent of the region’s residents develop and die of mesothelioma from exposure to eronite, a naturally occurring mineral fiber found in rock formations that is even more toxic than asbestos. Eronite has been used in the U.S. in road paving.
Drs. Carbone and Yang plan to conduct a clinical trial co-sponosored by the U.S. National Cancer Institute in Cappadocia to validate the serum biomarkers they discovered for the early detection of mesothelioma.
Their findings may have applications far beyond the villages of Turkey and lead to new ways to prevent and treat the disease. In the future, treatment approaches aimed at identifying people who are likely to develop mesothelioma based on elevated biomarkers and blocking chronic inflammation could reduce the risk of mesothelioma among workers exposed to asbestos.
“This generous gift is critical to support our efforts to generate discoveries that will aid in the prevention of mesothelioma and the development of new therapies,” Dr. Carbone said in a statement.
In recognition of that groundbreaking research, an anonymous donor has given the University of Hawaii Cancer Center a $3.58 million gift to support mesothelioma research, the university announced this month. The gift is the second largest in UH Cancer Center history.
“Mesothelioma is a serious public health problem,” said Virginia Hinshaw, chancellor of the University of Hawaii Manoa. “We’re proud that Dr. Carbone’s team is leading the world in this area of discovery. This gift validates their efforts and will help them remain at the forefront of thoracic oncology research.”
Closely associated with inhaling airborne asbestos fibers, mesothelioma produces an aggressive type of tumor. The current median survival from diagnosis is just 12 months, creating a need for more effective therapies to extend mesothelioma patients’ lives. Approximately 2,500 to 3,000 people in the U.S. are diagnosed with mesothelioma each year. Most were exposed to asbestos decades before cancer symptoms appeared.
Dr. Carbone and colleagues including Assistant Professor Haining Yang and Adjunct Professor Giovanni Gaudino have studied asbestos-related disease for more than a decade, analyzing how genetics, environmental carcinogens and viral infection interact to cause malignant mesothelioma.
In an article in the Proceedings of the National Academy of Sciences, Carbone and colleagues described how asbestos killed cells through a process called programmed cell necrosis that leads to the release of a protein molecule HMGB1. People exposed to asbestos have elevated levels of the protein in their blood. The protein begins an inflammatory chain reaction in tissue that causes the release of mutagens that promote tumor growth. Cancer often occurs in the presence of chronic inflammation. By interfering with the inflammatory reaction, it may be possible to decrease the occurrence of mesothelioma.
Many of the UH researchers’ findings have been based on work conducted in the villages of Capadoccia, a region of Turkey that has an extraordinarily high rate of mesothelioma deaths. Nearly 50 percent of the region’s residents develop and die of mesothelioma from exposure to eronite, a naturally occurring mineral fiber found in rock formations that is even more toxic than asbestos. Eronite has been used in the U.S. in road paving.
Drs. Carbone and Yang plan to conduct a clinical trial co-sponosored by the U.S. National Cancer Institute in Cappadocia to validate the serum biomarkers they discovered for the early detection of mesothelioma.
Their findings may have applications far beyond the villages of Turkey and lead to new ways to prevent and treat the disease. In the future, treatment approaches aimed at identifying people who are likely to develop mesothelioma based on elevated biomarkers and blocking chronic inflammation could reduce the risk of mesothelioma among workers exposed to asbestos.
“This generous gift is critical to support our efforts to generate discoveries that will aid in the prevention of mesothelioma and the development of new therapies,” Dr. Carbone said in a statement.
Monday, 26 April 2010
Mesothelioma Hope
Many patients and their loved ones may enjoy reading "Lean on Me - Cancer through a Carer's Eyes," a touching story by Lorraine Kember about her husband's battle with mesothelioma. Reading about the emotions the Kember family experienced may help provide insight into the road ahead for those newly diagnosed. To receive a complimentary copy of this book
Mesothelioma Nutrition
Without a current cure for mesothelioma, patients battling the cancer often want to fight it in every way possible. Nutritious eating is a wonderful way to instill mesothelioma hope and equip the immune system with positive fuel. The food and nutrients that we put into our bodies greatly affect our ability to heal and fight disease. Eating a balanced diet consisting of whole grains, proteins, dairy, fruits and vegetables enables the body to function properly and adequately fight infection and illness. Eating nutritious food while actively fighting mesothelioma through treatment may not cure the cancer, but fighting the disease from every angle will give patients the best possible outlook.
Mesothelioma patients undergoing various treatments may have additional nutritional concerns. Nutrition during chemotherapy is extremely important as the drugs used during treatment kill cancer cells, but simultaneously affect healthy cells as well, leaving the body in a weakened state. Many patients may experience side effects from the treatment, including nausea and diarrhea. Mild flavored foods such as whole grain toast may settle the stomach and be easier to keep down during treatment. To combat constipation, patients should select foods with a large amount of fiber such as apples, oatmeal and broccoli. Ensuring adequate protein consumption is also important and many patients include egg whites, beans, milk and lean meats in their daily diet.
Patients undergoing radiation therapy may also experience side effects such as vomiting and loss of appetite. Since radiation can zap energy, it is important to eat nutritious foods with healthy calories to fuel the body properly. Limiting the amount of salt, alcohol and caffeine ingested during treatment is also very important. Speaking with a doctor or a nutritionist can help a patient receive guidance about proper nutrition and recommended foods to eat or avoid during radiation.
It is also important for those recovering from cancer to be mindful of their diet. Additional information about nutrition and cancer recovery can be found in the Mesothelioma Cancer and Nutrition section of our Web site.
Sources:
Mesothelioma patients undergoing various treatments may have additional nutritional concerns. Nutrition during chemotherapy is extremely important as the drugs used during treatment kill cancer cells, but simultaneously affect healthy cells as well, leaving the body in a weakened state. Many patients may experience side effects from the treatment, including nausea and diarrhea. Mild flavored foods such as whole grain toast may settle the stomach and be easier to keep down during treatment. To combat constipation, patients should select foods with a large amount of fiber such as apples, oatmeal and broccoli. Ensuring adequate protein consumption is also important and many patients include egg whites, beans, milk and lean meats in their daily diet.
Patients undergoing radiation therapy may also experience side effects such as vomiting and loss of appetite. Since radiation can zap energy, it is important to eat nutritious foods with healthy calories to fuel the body properly. Limiting the amount of salt, alcohol and caffeine ingested during treatment is also very important. Speaking with a doctor or a nutritionist can help a patient receive guidance about proper nutrition and recommended foods to eat or avoid during radiation.
It is also important for those recovering from cancer to be mindful of their diet. Additional information about nutrition and cancer recovery can be found in the Mesothelioma Cancer and Nutrition section of our Web site.
Sources:
- Galateau-Salle, Francoise. Pathology of Malignant Mesothelioma. Springer-Verlag London Limited: London. 2006.
- Pass, I., Vogelzang, N., Carbone, M. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Transitional Therapies. Springer: New York. 2005.
- http://www.cancer.gov/cancerinfo/pdq/supportivecare/nutrition
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_ statistics_for_malignant_mesothelioma_29.asp?sitearea=
- http://www.cancer.org/downloads/PUB/DOCS/SECTION28/89.pdf
- http://clinicaltrials.gov/ct2/home
- http://www.impmeso.org/
- http://www.mayoclinic.com/health/mesothelioma/DS00779/DSECTION=treatments-and-drugs
- http://www.mayoclinic.com/print/mesothelioma/DS00779/DSECTION=all&METHOD=print
Mesothelioma Prognosis and Survival
Though many patients and their loved ones often get discouraged if the prognosis following a mesothelioma diagnosis comes back poor, it is important to remember that a number of patients have survived much longer than their initial prognosis suggested. Prognosis is generally poor because most patients do not exhibit symptoms of mesothelioma until 20 to 50 years after initial exposure to asbestos occurred, allowing the cancer to develop and mature in the body. The development of tests to aid in early diagnosis, such as the Mesomark blood test, will hopefully help mesothelioma patients receive treatment in the earlier stages of the cancer. Early diagnosis results in greater treatment options available to mesothelioma patients which can greatly improve a patient's prognosis.
Research reveals that mesothelioma patients who have survived for many years with the disease have commonly participated in some sort of therapy to enhance their immune system. Participation in clinical trials in immunology and other alternative therapies relating to the immune system have yielded positive results in some instances. Researchers theorize that mesothelioma likely results from immune suppression and mesothelioma survivors that participated in treatments to improve the immune system may have experienced positive results because of this participation.
Research reveals that mesothelioma patients who have survived for many years with the disease have commonly participated in some sort of therapy to enhance their immune system. Participation in clinical trials in immunology and other alternative therapies relating to the immune system have yielded positive results in some instances. Researchers theorize that mesothelioma likely results from immune suppression and mesothelioma survivors that participated in treatments to improve the immune system may have experienced positive results because of this participation.
Mesothelioma Cure
A mesothelioma cure seemed almost unattainable not long ago, but this negative outlook is beginning to change. Doctors and cancer specialists are constantly working towards the development of a cure and instilling mesothelioma hope in patients. During this search to find a cure for mesothelioma, stories of survival continue to surface, renewing hope and determination.
Mesothelioma Clinical Trials
any patients elect to participate in clinical trials as a way of building mesothelioma hope. Clinical trials are conducted to test up-and-coming treatments and medications before they are released and recommended to the public as a safe and effective way to treat an illness. The three stages of clinical trials test new drugs extensively, from the correct dosage required to the effectiveness of the drug. To participate in a clinical trial, a patient must first qualify for the study and meet specific qualifications.
Clinical trials are imperative in the search for a mesothelioma cure. As results and information are gathered from a study, the knowledge gained helps medical professionals come closer to the discovery of a cure. Each successful clinical trial renews mesothelioma hope for all patients around the world.
Clinical trials are imperative in the search for a mesothelioma cure. As results and information are gathered from a study, the knowledge gained helps medical professionals come closer to the discovery of a cure. Each successful clinical trial renews mesothelioma hope for all patients around the world.
Mesothelioma Treatments
There are several types of treatment available for patients with mesothelioma, some recommended more frequently than others. The most commonly used treatments are surgery, chemotherapy, and radiation therapy. In addition, some experimental treatments are becoming more widely used, or are showing some encouraging results in clinical trials. These treatments include photodynamic therapy, gene therapy, and immunotherapy, among others.
In an effort to help patients understand mesothelioma, Asbestos.com offers a complimentary packet that contains treatment information tailored to your specific diagnosis. The packet also covers the nation's top mesothelioma doctors and cancer centers, as well as financial assistance options to help cover medical costs. To receive your packet in the mail, please enter your information below.
In an effort to help patients understand mesothelioma, Asbestos.com offers a complimentary packet that contains treatment information tailored to your specific diagnosis. The packet also covers the nation's top mesothelioma doctors and cancer centers, as well as financial assistance options to help cover medical costs. To receive your packet in the mail, please enter your information below.
Sunday, 17 January 2010
What other kinds of information is available for people with mesothelioma?
What other kinds of information is available for people with mesothelioma?
There are numerous cancer web sites, some specific to mesothelioma. Because they are often difficult to locate, we have listed some relevant medical web sites that have information about mesothelioma.
American Institute for Cancer Research
(http://www.aicr.org)
American Thoracic Society
(http://www.thoracic.org/)
Canadian Cancer Society
(http://www.bc.cancer.ca)
MesotheliomaWeb
(http://www.mesotheliomaweb.org)
There are numerous cancer web sites, some specific to mesothelioma. Because they are often difficult to locate, we have listed some relevant medical web sites that have information about mesothelioma.
American Institute for Cancer Research
(http://www.aicr.org)
American Thoracic Society
(http://www.thoracic.org/)
Canadian Cancer Society
(http://www.bc.cancer.ca)
MesotheliomaWeb
(http://www.mesotheliomaweb.org)
Mesothelioma At A Glance
* Mesothelioma is a cancer that arises from the cells lining the chest or abdominal cavities.
* Mesothelioma typically results from exposure to asbestos.
* When mesothelioma affects the chest, the doctor may look inside the chest cavity with a special instrument called a thoracoscope.
* When mesothelioma affects the abdomen, the doctor may look inside the abdomen with a special tool called a peritoneoscope.
* Mesothelioma is diagnosed by a biopsy.
* The outlook for patients with mesothelioma depends on how early the disease is detected and how aggressively it is treated.
* Mesothelioma typically results from exposure to asbestos.
* When mesothelioma affects the chest, the doctor may look inside the chest cavity with a special instrument called a thoracoscope.
* When mesothelioma affects the abdomen, the doctor may look inside the abdomen with a special tool called a peritoneoscope.
* Mesothelioma is diagnosed by a biopsy.
* The outlook for patients with mesothelioma depends on how early the disease is detected and how aggressively it is treated.
Additional information
Surgery: There are several types of surgery used in treating mesothelioma.
* A pleurectomy is the removal of part of the chest or abdomen lining and some of the tissue around it.
* Depending on how far the cancer has spread, a lung also may be removed in an operation called a pneumonectomy.
* In an extrapleural pneumonectomy, the lung is removed along with the lining and diaphragm (the muscle that helps you breathe) on the affected side. In this surgery, the lining around the heart is also removed.
* Sometimes a pleurectomy/decortication is performed. In this surgery, the lining of the lung is removed along with as much of the tumor as possible.
Radiation therapy uses high-energy X-rays to kill cancer cells and shrink tumors. Radiation may come from a machine outside the body (external radiation therapy) or from putting materials that produce radiation (radioisotopes) through thin plastic tubes in the area where the cancer cells are found (internal radiation therapy).
If fluid has collected in the chest or abdomen, your doctor may drain the fluid out of your body by putting in a needle into the chest or abdomen and using gentle suction to remove the fluid. If fluid is removed from the chest, this is called thoracentesis. If fluid is removed from the abdomen, this is called paracentesis. Your doctor may also put drugs through a tube into the chest to prevent more fluid from accumulating.
Chemotherapy is the use of drugs to kill cancer cells. Chemotherapy may be administered by pill, or it may be put into the body by a needle in the vein or muscle.
Chemotherapeutic agents can be administered either systemically (through the bloodstream) or intrapleurally (in the pleural cavity). When it is administered intrapleurally, the treatment is localized at the site of the tumor. These drugs are generally very toxic and you should discuss their use very carefully with your physician.
* A pleurectomy is the removal of part of the chest or abdomen lining and some of the tissue around it.
* Depending on how far the cancer has spread, a lung also may be removed in an operation called a pneumonectomy.
* In an extrapleural pneumonectomy, the lung is removed along with the lining and diaphragm (the muscle that helps you breathe) on the affected side. In this surgery, the lining around the heart is also removed.
* Sometimes a pleurectomy/decortication is performed. In this surgery, the lining of the lung is removed along with as much of the tumor as possible.
Radiation therapy uses high-energy X-rays to kill cancer cells and shrink tumors. Radiation may come from a machine outside the body (external radiation therapy) or from putting materials that produce radiation (radioisotopes) through thin plastic tubes in the area where the cancer cells are found (internal radiation therapy).
If fluid has collected in the chest or abdomen, your doctor may drain the fluid out of your body by putting in a needle into the chest or abdomen and using gentle suction to remove the fluid. If fluid is removed from the chest, this is called thoracentesis. If fluid is removed from the abdomen, this is called paracentesis. Your doctor may also put drugs through a tube into the chest to prevent more fluid from accumulating.
Chemotherapy is the use of drugs to kill cancer cells. Chemotherapy may be administered by pill, or it may be put into the body by a needle in the vein or muscle.
Chemotherapeutic agents can be administered either systemically (through the bloodstream) or intrapleurally (in the pleural cavity). When it is administered intrapleurally, the treatment is localized at the site of the tumor. These drugs are generally very toxic and you should discuss their use very carefully with your physician.
Is there any promising research or are there promising drugs for mesothelioma?
New approaches being studied
New approaches to treat malignant mesothelioma are currently being tested. They often combine traditional treatments or include something entirely new. They include
* Promising drugs
o L-NDDP (Platar): Intrapleural administration of this platinum product is designed to overcome the toxicity and drug resistance currently limiting the usefulness of platinum drugs like Cisplatin. NOTE: A recent trial produced remission in two patients.
o Endostatin has been shown to work with angiostatin in destroying a tumors' ability to grow blood vessels without harming normal cells.
o Lovastatin is a cholesterol drug shown in a recent study to potentially inhibit mesothelioma cancer cell growth.
o Intrapleural interferon gamma is the direct administration of the anti-cancer drug interferon gamma.
* Photodynamic therapy kills cancer cells using the energy of light.
* Immunotherapy treats cancer by helping the immune system fight the disease.
* Gene therapy treats cancer by correcting the genetic deficits that allow tumors to develop. A September 1999 study found that interferon interleukin prevented the growth of mesothelioma cells in mice.
Research is being conducted at various cancer centers all over the United States.
A recent study involving L-NDDP produced two cases of remission in mesothelioma patients. Another study found that a drug known as Lovastatin may hold promise for mesothelioma patients.
To learn more about mesothelioma clinical studies and journal medical journal articles, visit the Mesothelioma Web (http://www.mesotheliomaweb.org).
Brigham system: variables of tumor resectability and nodal status
* Stage I: resectable mesothelioma and no lymph node involvement
* Stage II: resectable mesothelioma but with lymph node involvement
* Stage III: unresectable mesothelioma extending into chest wall, heart, or through diaphragm, peritoneum; with or without extrathoracic lymph-node involvement
* Stage II: resectable mesothelioma but with lymph node involvement
* Stage III: unresectable mesothelioma extending into chest wall, heart, or through diaphragm, peritoneum; with or without extrathoracic lymph-node involvement
What is the treatment for mesothelioma?
There are three traditional kinds of treatment for patients with malignant mesothelioma. Often two or more of these are combined in the course of treatment:
* surgery (taking out the cancer),
* radiation therapy (using high-dose X-rays or other high-energy rays to kill cancer cells), and
* chemotherapy (using drugs to fight the cancer).
* surgery (taking out the cancer),
* radiation therapy (using high-dose X-rays or other high-energy rays to kill cancer cells), and
* chemotherapy (using drugs to fight the cancer).
Butchart system extent of primary tumor mass
* Stage I: Mesothelioma is present in the right or left pleura and may also involve the diaphragm on the same side.
* Stage II: Mesothelioma invades the chest wall or involves the esophagus, heart, or pleura on both sides. Lymph nodes in the chest may also be involved.
* Stage III: Mesothelioma has penetrated through the diaphragm into the lining of the abdominal cavity or peritoneum. Lymph nodes beyond those in the chest may also be involved.
* Stage IV: There is evidence of metastasis or spread through the bloodstream to other organs.
The more recent TNM system considers variables of tumor in mass and spread, lymph node involvement, and metastasis.
* Stage II: Mesothelioma invades the chest wall or involves the esophagus, heart, or pleura on both sides. Lymph nodes in the chest may also be involved.
* Stage III: Mesothelioma has penetrated through the diaphragm into the lining of the abdominal cavity or peritoneum. Lymph nodes beyond those in the chest may also be involved.
* Stage IV: There is evidence of metastasis or spread through the bloodstream to other organs.
The more recent TNM system considers variables of tumor in mass and spread, lymph node involvement, and metastasis.
TNM system: variables of T (tumor), N (lymph nodes), and M (metastasis)
* Stage I: Mesothelioma involves right or left pleura and may also have spread to the lung, pericardium, or diaphragm on the same side. Lymph nodes are not involved.
* Stage II: Mesothelioma has spread from the pleura on one side to nearby lymph nodes next to the lung on the same side. It may also have spread into the lung, pericardium, or diaphragm on the same side.
* Stage III: Mesothelioma is now in the chest wall, muscle, ribs, heart, esophagus, or other organs in the chest on the same side with or without spread to lymph nodes on the same side as the primary tumor.
* Stage IV: Mesothelioma has spread into the lymph nodes in the chest on the side opposite the primary tumor, extended to the pleura or lung on the opposite side, or directly extended into organs in the abdominal cavity or neck. Any distant metastases is included in this stage.
The Brigham system is the latest system and stages mesothelioma according to resectability (the ability to surgically remove the tumor) and lymph node involvement.
* Stage II: Mesothelioma has spread from the pleura on one side to nearby lymph nodes next to the lung on the same side. It may also have spread into the lung, pericardium, or diaphragm on the same side.
* Stage III: Mesothelioma is now in the chest wall, muscle, ribs, heart, esophagus, or other organs in the chest on the same side with or without spread to lymph nodes on the same side as the primary tumor.
* Stage IV: Mesothelioma has spread into the lymph nodes in the chest on the side opposite the primary tumor, extended to the pleura or lung on the opposite side, or directly extended into organs in the abdominal cavity or neck. Any distant metastases is included in this stage.
The Brigham system is the latest system and stages mesothelioma according to resectability (the ability to surgically remove the tumor) and lymph node involvement.
Subscribe to:
Posts (Atom)